Which first-line treatment is superior in advanced colorectal cancer: XELOX or pviFOX?

Cassidy, J. (2007) Which first-line treatment is superior in advanced colorectal cancer: XELOX or pviFOX? Nature Clinical Practice Oncology, 4(5), pp. 280-281. (doi: 10.1038/ncponc0792)

Full text not currently available from Enlighten.


Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cassidy, Professor James
Authors: Cassidy, J.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Nature Clinical Practice Oncology
ISSN:1743-4254

University Staff: Request a correction | Enlighten Editors: Update this record